Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Reminder: invitation to the presentation of Swedbank’s first-quarter results 2022

Swedbank’s Quarterly report will be published on Thursday 28 April at 7.00 a.m. CET. Investors and analysts: Conference call on 28 April at 8.30 a.m. CETJens Henriksson (President and CEO), Anders Karlsson (CFO), Rolf Marquardt (CRO) and Annie Ho (Head of Investor Relations) will present the results. The conference call will be held in English and broadcasted live on www.swedbank.com/ir, where a recording also will be available following the call. New dial-in details (pass code not needed)Participants may call the following numbers 10-15 minutes before the conference call starts:

Internet Vikings Celebrate Their 14th Anniversary by Receiving Prestigious Global Gaming Awards

The week before, global iGaming hosting solutions supplier Internet Vikings received the Services Provider of the Year award by Global Gaming Awards (GGA), acknowledging the company’s achievements and input into the industry. “I could not be more proud”, said Internet Vikings’ co-founder and CCO, Rickard Vikström. “The entire team has worked hard to help our company rise to the level it is at today. To us the award is more than a status. It means that the iGaming industry sees and recognises the value we bring to the businesses.” Internet Vikings originated in Stockholm in 2008.

SelectImmune Pharma receives approval to conduct a placebo-controlled clinical study of Bladder Pain

Selectimmune Pharma is pleased to announce that the Swedish Medical Products Agency (Läkemedelsverket) has approved the application to conduct a placebo-controlled clinical study using IL1-RA for the treatment of Bladder Pain Syndrome.Bladder pain syndrome is a highly painful chronic condition that severely impairs the quality of life of affected patients. Numerous therapeutic approaches have been tested, but currently, no specific therapies are available. Regular painkillers, or even morphine fails to provide adequate symptom relief and even after surgical removal of damaged parts of the

DNB Markets - Nexam Chemical: Short-term pain, long-term gain

We have lowered our 2022e sales by 9% following a weaker short-term outlook for wind power. We find the company’s implicit 2022 sales target of SEK275m–325m challenging, but still consider it well positioned to reach its targeted 25% sales growth annually, with stable profitability over a cycle. Following the Q1 results and a change of analyst, we keep our fair value of SEK14–19.Q1 review. Sales were 4% below our forecast, primarily driven by negative growth in Performance Chemicals due to a decline in demand for wind power. Performance Masterbatch, on the other hand, saw strong growth,

Hexagon Composites ASA: Flagging – Annual General Meeting 28 April 2022

25 April 2022: Knut Flakk, Chairman of the Board of Hexagon Composites ASA, has in connection with the Annual General Meeting on 28 April 2022 received proxies without voting instructions for a total of 7,343,396 shares, corresponding to 3.64 % of Hexagon’s share capital. The authorizations only apply to the general meeting on 28 April 2022.  In addition, Knut Flakk controls 27,334,969 shares in Hexagon Composites, corresponding to 13.56% of the share capital. This means that for the Annual General Meeting on 28 April 2022, Knut Flakk controls a total of 17.20 % of the share capital in

Advenica becomes integration partner to Axis Communications

Advenica, the Swedish supplier of cybersecurity solutions, has started a cooperation with Axis Communications and has now enrolled as an Axis Communications technology integration partner.Surveillance Networks always have high security requirements and therefore are more often than not closed off from any outside connections.  Advenica aims at providing integrated, high assurance, state of the art Cross Domain Solutions (CDS) on the edge of surveillance networks. The goal is to provide the best available protection against malicious attacks, or zero-day vulnerability exploits on the secured

Adapteo hires new CEO – recruits acclaimed leader from Elis

On 27 June, Johanna Persson will take over the role of President and CEO of Adapteo Group. Until recently, Johanna has been the Chief Operating Officer of the Nordic organisation at the circular textile service company Elis. With this recruitment, Adapteo takes yet another step towards becoming one of the leading companies in sustainability in the European construction and real estate industry. Adapteo is the leading partner in adaptable and circular building solutions in Northern Europe, and has an ambition to become a driving force in sustainability within the industry. It is on the

HC Andersen Capital Events 25/4: Meet the management in ExpreS2ion Biotechnologies and NeoDynamics

HC Andersen Capital is today hosting digital events where you can meet and ask questions directly to the top management. It is free for all to attend.Expres2ion Biotechnologies - Rights IssueExpres2ion Biotechnologies have announced a new share issue with preferential rights for the Company’s existing shareholders. The Rights Issue is fully covered by subscription undertakings. The gross proceeds of approximately SEK 73 million will primarily be used as to advance the breast cancer vaccine candidate ES2B-C001 to completion of the preclinical safety studies, advance other pipeline

Nobina wins new contract in Norway

Under a new contract, Østfold Kollektivtrafikk has chosen Nobina to operate and develop public transport services in Fredrikstad and Sarpsborg and surrounding areas. As always, Nobina will focus on sustainability, safety and a welcoming reception.As part of offering sustainable travel, most of the 139 scheduled buses will run on electricity while the remainder will run entirely on biogas. Moreover, the bus-washing facilities are certified under the Nordic Swan and the depots are designed to contribute towards overall sustainability through the efficient use of energy and water. All buses

Flagging notification in accordance with Chapter 9 Section 10 of the Finnish Securities Markets Act

Basware Corporation, stock exchange release, 25 April 2022 at 10:00 a.m. EESTBasware Corporation has received on 21 April 2022 the following notification pursuant to Chapter 9, Section 5 of the Finnish Securities Market Act from The Goldman Sachs Group, Inc. according to which their total holding of shares of Basware Corporation has decreased below five (5) percent on 21 April 2022. According to the notification, the reason for the notification was an acquisition or disposal of financial instruments. Basware Corporation has one series of shares in which each share carries one vote. The

Directed free share issue in connection with the payment of additional purchase price of Lumise Oy

Relais Group Plc, Company Release 25 April 2022 at 9.45 a.m. EET The Board of Directors of Relais Group Plc has decided on a directed free share issue (“Directed Share Issue”) and issues a maximum total of 64,407 new Relais Group shares (“Additional Shares”) to be subscribed for free of charge by Kari Kauhanen and other former shareholders of Lumise Oy. The Directed Share Issue will be carried out in derogation of the pre-emptive subscription right of the shareholders on the authorization of the Company's Annual General Meeting held on 13 April 2022. The Additional Shares issued in

Norway Royal Salmon ASA (NRS): Change of CEO

The appointment of the interim CEO of Norway Royal Salmon ASA ("NRS") Klaus Hatlebrekke, will expire with effect from Monday 25 April 2022. Hatlebrekke will on the same date return to his previous position as COO of business development. Charles Høstlund, who was CEO of NRS from 2014 till September 2021, will be appointed new interim CEO from Monday 25 April 2022. -I have accepted to lead NRS in an interim period, and it is exciting to be back with the company. I am looking forward to seeing many familiar faces the coming weeks, says Charles Høstlund. -It is natural to make a

Asetek Presents First Quarter 2022 Results on Thursday, 28 April

Asetek will release its financial results for the first quarter of 2022 on Thursday, 28 April at 10:30 CEST. CEO André Sloth Eriksen and CFO Peter Dam Madsen will present the Company's results at 12:30 CEST and invites investors, analysts and media to join the presentation. The presentation is expected to last up to one hour, including Q&A, and can be followed via live webcast or conference call. Webcast - audio and slide presentation: Please join the results webcast via the following link: https://streams.eventcdn.net/asetek/2022q1/ 

Gram Car Carriers ASA: Invitation to presentation of Q1 2022 results

Oslo, 25 April 2022 – Gram Car Carriers ASA (“GCC”), the world’s third largest car carrier tonnage provider, is pleased to invite investors, analysts and media to its Q1 2021 results presentation on Thursday, 28 April 2022 at 11:00 CET. The report and presentation will be made available at 06:30 AM (CET) at gramcar.com and newsweb.no . The Q1 presentation will be hosted by the CEO Georg A. Whist and the CFO Gunnar S. Koløen. The presentation will be held in English and conducted as a webcast with a live Q&A session at the end. Questions may be submitted in

Capio Group Services AB completes the recommended cash offer to the shareholders of GHP Specialty Care AB and extends the acceptance period

This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important information” at the end of this press release

Kebni Inertial Sensing receives 2.5 MSEK order

KebNi AB (publ.) receives an order regarding NAV02 inertial measurement units with a total value of 247 800 EUR (approx. 2.5 MSEK)Stockholm, 25 April 2022 – Kebni announces today that they have received an order for multiple inertial measurement units (IMU) from a leading mining industry. The total order value amounts to approx. 2.5 MSEK and deliveries will be finalized by the end of 2023.Kebni’s inertial sensing units play a key role for navigation and system safety on the customer’s product range of underground vehicles, where they are installed as a vital subsystem on every autonomous

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF IRRAS AB (PUBL)

The shareholders of IRRAS AB (publ), org.nr 556872-7134 (”the Company”), are hereby invited to the Annual General Meeting to be held on Tuesday 24 May 2022. The Board of Directors has, in accordance with the Swedish Act on temporary exceptions to facilitate the execution of general meetings in companies and other associations (Sw. lagen (2022:121) om tillfälliga undantag för att underlätta genomförandet av bolags- och föreningsstämmor), resolved that the Annual General Meeting should be conducted without the psysical presence of shareholders, representatives or third parties and that the

IRRAS Announces Changed Publication Date for the Q1 2022 Interim Report

Stockholm, Sweden (April 25, 2022) – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that the publication of the company’s interim report for the period from January to March 2022 (“Q1 2022 Interim Report”) will be published on Wednesday, 27 April 2022. Financial calendar for 2022 Report Previously Announced Date New DateQ1 2022 interim report 10 May 2022 27 April 2022Q2 2022 interim report 22 July 2022 UnchangedQ3 2022 interim

Wulff Group Plc’s Interim Report for January 1 – March 31, 2022

This is a summary of Wulff Group Plc’s Interim Report for January-March 2022. Wulff Group’s Interim Report as a whole is attached as a PDF file to this stock exchange release and it is also available on the company’s website www.wulff.fi. The best Q1 in Wulff’s history: net sales increased by 67,2% and operating profit doubled 1.1.-31.3.2022 BRIEFLY · Net sales totalled EUR 25.6 million (15.3), increased by 67.2%. · EBITDA and comparable EBITDA were EUR 1.8 million (0.9). · Operating profit and comparable operating profit (EBIT) amounted to EUR 1.2 million (0.6). ·

Nederman invests in a new manufacturing, logistics and innovation centre in Helsingborg

The environmental technology and industrial air filtration company Nederman, founded in Helsingborg, is developing its operations in Helsingborg by investing in a new manufacturing and logistics facility as well as establishing a global innovation centre.Nederman have production and development expertise, as well as the head office for the Nederman Group and two of its four divisions in Helsingborg. The Nederman Group today employs around 2 200 people whereof 180 are located in Helsingborg. Together with the new manufacturing and logistics unit, the company is establishing the Nederman

Invitation to presentation of LMK Group’s Q1 2022 report

LMK Group will publish its Q1 2022 report on 4 May 2022 at 07:45 CET. In connection with this, LMK Group invites investors, analysts and the media to a conference call and webcast on the same day at 09:00 CET.The presentation will be held in English by CEO Walker Kinman and CFO Erik Bergman and will conclude with a Q&A session. Questions can be asked on the telephone conference call or in written form through the webcast. No preregistration is needed. Date and time4 May 2022 at 09:00 CET Webcasthttps://tv.streamfabriken.com/lmk-group-q1-2022 Phone numberTo participate via

2020 Bulkers Ltd. (2020) – Invitation to webcast and conference call Q1 2022 results

2020 Bulkers Ltd. will release its financial results for the first quarter of 2022 on Wednesday, April 27, 2022. A conference call and webcast will be held at 3:00 PM CET. The earnings report and presentation will be available from the Investor Relations section on www.2020bulkers.com on the same day. In order to listen to the presentation, you may do one of the following: Listen-only webcast (including the slide presentation): https://edge.media-server.com/mmc/p/vhj298wj or you can click the “Webcast” link on www.2020bulkers.com/investor-relations/ Telephone conference Dial in

Tremelimumab US Priority Review for Imfinzi combo

25 April 2022 07:00 BST Tremelimumab accepted under Priority Review in the US for patientswith unresectable liver cancer in combination with Imfinzi STRIDE regimen of a single priming dose of tremelimumab added to Imfinzi is the first dual immune checkpoint blockade regimen to improve overall survival in a Phase III trial in this setting AstraZeneca's Biologics License Application (BLA) for tremelimumab has been accepted for Priority Review in the US, supporting the indication of a single priming dose of the anti-CTLA4 antibody added to Imfinzi (durvalumab) for the treatment of

BioGaia’s result for first quarter to exceed market expectations

(Figures in brackets refer to the same period the previous year) BioGaia´s sales for the first quarter has been positively impacted by an increased demand mainly from the European market. Sales for the first quarter are preliminarily estimated at SEK 284 million (202), up 41%. Operating profit for the first quarter is preliminarily estimated at SEK 95 million (64), up 48%. BioGaia will publish the interim report for the first quarter on Friday, 6 May 2022 at 8:00 a.m., followed by a teleconference at 9:30 a.m. Latest press releases from BioGaia: 05.04.2022 Notice to attend

There are no items matching the current filter
There are no more items matching the current filter
Back to top